JAMA

JAMA, the Journal of the American Medical Association, is a peer-reviewed general medical journal published 48 times a year by the American Medical Association, established in 1883, among the most widely circulated general medical journals in the world, publishing original research, reviews and editorials covering all aspects of biomedicine, with a 2025 Journal Impact Factor of 65.4（美国医学会杂志，JAMA）是 American Medical Association（美国医学会）出版的综合医学期刊，1883 年创刊，每年出版 48 期，为全球发行量最大的综合医学期刊之一，刊载覆盖生物医学各领域的原创研究、综述与社论，2025 年影响因子为 65.4。

Scope

• It publishes original, important and valid peer-reviewed articles on a diverse range of medical topics刊载经同行评审、具原创性、重要性与科学有效性的论文，覆盖广泛的医学议题。
• Its coverage spans basic and clinical science and supports physicians' continuing education in both内容涵盖基础与临床科学，并为医生提供基础与临床科学的继续教育。
• It helps physicians remain informed across multiple areas of medicine, including developments in fields other than their own帮助医生持续了解多个医学领域，包括自身专业之外的进展。
• It informs readers about medicine and public health, including their cultural, sociopolitical, ethical, legal, environmental, economic, structural and historical dimensions向读者介绍医学与公共卫生，包括其文化、社会政治、伦理、法律、环境、经济、结构与历史维度。
• It fosters responsible and balanced debate and promotes diversity, equity and inclusion in medical research, clinical care, health policy and society促进负责任而均衡的讨论，并推动医学研究、临床照护、卫生政策与社会中的多样性、公平与包容。
• It aims to improve health and health care internationally by elevating the quality of medical care, disease prevention and research旨在通过提升医疗照护、疾病预防与研究质量，改善全球健康与卫生服务。
• Its key objective is to promote the science and art of medicine and the betterment of the public health, with a social responsibility to promulgate truth in science and medicine and to promote the integrity of science其宗旨是促进医学科学与医术、增进公众健康，并承担传播科学与医学真理、维护科学诚信的社会责任。

History

• It was established in 1883 when it replaced the annual Transactions of the American Medical Association (published 1848-1882), with Nathan Smith Davis as its first editor and George H. Simmons as its second editor from 1889该刊 1883 年创刊，取代此前出版的年刊《美国医学会汇刊》（1848—1882 年），首任主编为 Nathan Smith Davis，1889 年由 George H. Simmons 接任第二任主编。^[1]
• It has been published continuously since 1883 by the American Medical Association, based in Chicago该刊自 1883 年起由总部位于芝加哥的美国医学会持续出版。
• It is issued 48 times a year in print and online editions, with new articles published online every weekday每年出版 48 期纸质与在线版本，并在每个工作日在线发布新文章。
• Without author fees, all research articles become free to access online 6 months after publication该刊不向作者收费，所有研究论文在发表六个月后于网上免费开放。
• Its editor-in-chief Kirsten Bibbins-Domingo, the 17th in the journal's history, succeeded Howard C. Bauchner (2011-2021), after Catherine D. DeAngelis (2000-2011) and George D. Lundberg (1982-1999)现任主编 Kirsten Bibbins-Domingo 是该刊第 17 任主编，其前任依次为 George D. Lundberg（1982—1999）、Catherine D. DeAngelis（2000—2011）与 Howard C. Bauchner（2011—2021）。
• It is a member of the JAMA Network and of the International Committee of Medical Journal Editors, and cosponsors the International Congress on Peer Review and Biomedical Publication该刊是 JAMA Network 与国际医学期刊编辑委员会（ICMJE）的成员，并共同主办同行评审与生物医学出版国际会议。
• Its journal impact factor was 55.0 in 2024 and 65.4 in 2025, having stood at 63.5 in 2023其影响因子 2024 年为 55.0、2025 年为 65.4，2023 年则为 63.5。

Editors

• The editor-in-chief is Kirsten Bibbins-Domingo, MD, PhD, MAS, the Lee Goldman MD Endowed Professor of Medicine and Professor of Epidemiology and Biostatistics at the University of California, San Francisco, who took the post in 2022现任主编为 Kirsten Bibbins-Domingo（MD、PhD、MAS），加州大学旧金山分校 Lee Goldman 医学讲席教授兼流行病学与生物统计学教授，2022 年上任。
• The executive editor is Gregory Curfman, MD执行主编为 Gregory Curfman（MD）。
• The senior editors are Derek C. Angus, Philip Greenland and Christopher C. Muth资深编辑为 Derek C. Angus、Philip Greenland 与 Christopher C. Muth。
• The associate editors include Ethan Basch, Linda Brubaker, Rafael Campo, Anne Rentoumis Cappola, Thomas B. Cole, Carolyn J. Crandall and W. Gregory Feero副编辑包括 Ethan Basch、Linda Brubaker、Rafael Campo、Anne Rentoumis Cappola、Thomas B. Cole、Carolyn J. Crandall 与 W. Gregory Feero 等。
• It uses single-blind peer review, so that authors' names and affiliations are known to reviewers while reviewer identities are not revealed to authors该刊采用单盲同行评审，评审人可知作者姓名与单位，而作者不知评审人身份。
• Manuscripts are submitted through the JAMA submission system, and papers not accepted by JAMA may be referred to a JAMA Network specialty journal or to JAMA Network Open稿件经 JAMA 投稿系统提交；未被 JAMA 录用的论文可转投 JAMA Network 专科期刊或 JAMA Network Open。
• It has an acceptance rate of about 12% of more than 10,200 annual submissions and 5% of more than 5,500 research manuscripts, with a median time to first decision of 3 days without external review and 29 days with review其录用率约为每年逾 10200 篇投稿的 12%、逾 5500 篇研究稿的 5%，无需外审时首次决定中位 3 天、外审后为 29 天。